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1. Introduction 
Aminoacyl tRNA’s which play a key role in protein 
synthesis have been shown to participate in other types 
of peptide bond synthesis not involving ribosomes, 
GTP or Mg’+ ions. This reaction catalyzed by soluble 
incorporation system is present in the ribosome free 
supernatant fluid and is specific for leucine, phenyla- 
lanine, and tryptophane in bacteria [l-3] and for 
arginine in eukaryotic ells [4,5]. In each case a single 
amino acid is added to the amino terminus of a speci- 
fic preformed acceptor molecule(s). The existence of 
five isoaccepting species of tRNA for leucine raises 
the question whether there is a specificity in the uti- 
lization of different leu-tRNA’s in the soluble incor- 
poration system. The present study is an attempt o 
answer this question. Four of the leu-tRNA species 
were prepared free from cross contamination of each 
other and were found to transfer leucine to proteins 
in the system. However, the soluble incorporation 
systems appeared to have a much higher affinity for 
leu-tRNA,, and leu-tRNAS than for leu-tRNAs and 
-tRNA,. On the other hand, in MSzRNA directed 
protein synthesis, leu-tRNA, and leu-tRNA, were bet- 
ter utilized. 
2. Materials and methods 
3H-Leucine (sp. act. 59.1 ci/mmole) was purchased 
from New England Nuclear. The soluble system and 
partially purified aminoacyl-tRNA synthetase were 
prepared from E. coli Kn-P678-54 as described pre- 
viously [2]. Soluble incorporation system isolated 
North-HolIand Publishing Company - Amsterdam 
from the Streptomycin concentrate fraction (SM frac- 
tion) [2] which had most of the leucine transferring 
activity was used in these studies. Transfer RNA of 
E. coli B (obtained from General Biochemicals) was 
used to prepare 3H-leu-tRNA in the presence of all 
other amino acids and leucovorin according to the pro- 
cedures described [6] . The isoaccepting leu-tRNA spe- 
cies were separated by the reverse phase chromato- 
graphy (RPC) according to Kelmers and Heatherly who- 
se nomenclature of leu-tRNA was adopted [7]. As 
shown in fig. 1 the leu-tRNA fractions from each peak 
were pooled and recovered by ethanol precipitation and 
slow filtration on millipore filters (HA 0.45~). The re- 
tained labeled tRNA was eluted in a minimum volume 
of water and stored frozen at -80°C. E. coli Q13 ri- 
bosomes, initiation factors, elongation factors EFT, 
EFG, and M&RNA were prepared as described [8]. 
Fraction Number 
Fig. 1. Separation of isoaccepting leu-tRNA by reverse phase 
column (RPC) chromatography. A total of 355 pg of ‘H 
leu-tRNA (1735 cpm/pg tRNA) was applied on RPC in two 
batches and the fractions corresponding toeach peak were 
pooled as described in Materials and methods. 
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The reaction mixture for transfer of leucine from leu- 
tRNA into protein contained (in pmoles/OS ml): Tris- 
HCl pH 7.8,40; X1,25; 2-mercaptoethanol, 3; in 
addition to the SM fraction and leu-tRNA’s as indica- 
ted in the figure legends. The incorporation of amino 
acids into protein was measured as radioactivity preci- 
pitable with hot TCA by the filter paper disc method 
[9]. Incorporation of leucine from leu-tRNA into 
protein by the ribosomal system was carried out at 
37°C for 30 min in the reaction mixture containing 
the following in pmoles/O.l ml, Tris-HCl pH 7.8, 
5;MgCl, 0,75,NH&12.5, KC1 1 5,2-mercaptoetha- 
no1 0.7, and GTP 0.04; in addition ribosomes 320 pg, 
initiation factors 62.5 I-(8, EFT 59.5 pg, EFG 8.3 pg, 
’ 2 C-aminoacyl tRNA (-leu tRNA) 23.5 pg, MS2 RNA 
20 pg, and leu-tRNA species as indicated. Protein was 
determined by the method of Lowry [lo] . 
3. Results 
The separation profile of four isoaccepting leu- 
tRNA’s is shown in fig. 1. Rechromatography of the 
first large peak of leu-tRNA separated two components, 
leu-tRNAr and leu-tRNA2. Thus, pooled fraction from 
this peak leu-tRNA, indicated in fig. 1 was rechroma- 
tographed on RPC before use. The purity of each leu- 
tRNA species was established by ribosomal binding ex- 
periments in the presence of polynucleotides contain- 
ing codons for leucine (data not shown) [ 111. The 
time course of the transfer of leucine from four leu- 
tRNA species to protein fraction is shown in fig 2. 
Leu-tRNA2 could not be prepared free from leu-tRNA, 
in sufficient amounts and was not tested. The kinetics 
of leucine transfer from leu-tRNAi and leu-tRNAs 
were very similar while leu-tRNA3 was less efficiently 
utilized. The plateau after 6 min was most probably due 
to deacylation of the leu-tRNA’s. Table 1 shows that 
the incorporation of leucine from leu-tRNA I and leu- 
tRNAS was at least wice that from leu-tRNA, or leu- 
tRNA, . These values represent the final level of incor- 
poration with the various leu-tRNA’s. The different 
rates at which each of the species is utilized could be 
due to the different affinities of the enzyme for the 
leu-tRNA’s. That this is the case is shown in the 
Lineweaver-Burk plots for the four leu-tRNA’s in 
fig. 3. The apparent Km value for each of the leu- 
tRNA’s calculated from these plots is given in table 1. 
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Fig. 2. Time course of incorporation of leucine from leu- 
tRNA, , -tRNA,, -tRNA, and -tRNA,. The reaction 
mixture (134 ~1) contained 292 lg SM fraction and leu-tRNA, 
(5670 cpm) leu-tRNA, (4800 cpm), leu-tRNA, (6620 cpm) 
or leu-tRNA, (5870 cpm) in buffered salts as described in 
Materials and methods. Aliquots of 20 ~1 were withdrawn for 
assay, 
It can be seen that the affinities of the enzymes for 
leu-tRNAr and leu-tRNAS are 7 and 5 times greater 
than for leu-tRNAs and the efficiency of utilization 
of leu-tRNA’s expressed as % utilized in 6 min approx- 
imately corresponds to affinity of each leu-tRNA 
for the system. On the other hand phenylalanyl tRNA 
which is also a substrate had a low affinity for the sys- 
tem but is efficiently utilized in the transfer eaction. 
Since all the four leu-tRNA species tested functioned 
in the transfer eaction, albeit with different efficien- 
cies, it was of interest o study and compare their utili- 
zation in in vitro protein synthesis involving ribosomes 
and messenger RNA. Thus, the cell free E. coli riboso- 
mal system programmed with MSaRNA was used to stu- 
dy the incorporation of leucine from 3 H leu-tRNA spe- 
cies into phage related proteins. Incorporation of leu- 
tine in this system was dependent upon added messen- 
ger RNA, initiation and elongation factors. The percen- 
tage of leucine incorporated into protein from each of 
the four species is shown in table 1. In contrast o the 
results obtained in the soluble system, leu-tRNA3 was 
utilized best in the ribosomal system and leu-tRNA, 
and leu-tRNAs to a lesser extent. Since in the riboso- 
mal system the utilization of each species is dependent 
on the presence of the corresponding codons in the 
messenger, the results uggest that the codons for leu- 
tRNAi and leu-tRNAs are present less frequently in 
the MS2RNA sequence. In the in vitro protein synthe- 
sis programmed by M&RNA the main product is a 
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Fig. 3. Double reciprocal plots of initial rates of leucine incorporation versus leu-tRNA concentration. The total reaction mixture 
(200 ~1) containing 109.5 I.cg of SM fraction and varying amounts of labeled leu-tRNA was incubated at 37°C for 1 min. Initial 
rates of incorporation at different substrate concentrations were measured as given in text. A) leu-tRNA, , B) leu-tRNA, , C) leu- 
tRNA, and D) leu-tRNA, . 
phage coat protein [ 121 which has seven leucine resi- ribosomal binding [ 1 l] and incorporation experiments 
dues none of which are coded by the codons for leu- [ 141 with isoaccepting leucyl-tRNA’s and synthetic 
tRNA 1 or leu-tRNAs [ 131. The observed limited in- polynucleotides have shown clear codon specificities 
corporation of leu-tRNAr and leu-tRNA5 may be due only for leu-tRNAr (CUG) and leu-tRNA5 (UUG) while 
to the presence of codons for these two tRNA’s in the the others in general respond to nucleotides having 
message coding for the phage RNA synthetase. The high U and C content. 
Table 1 
Apparent _Km values for isoaccepting leu-tRNA’s and comparison of their utiliza.. 
tion in the soluble system and by E. cob ribosomes programmed with MS, RNA 
K* _m 
values % Utilized 
tRNA Species (pmoles/0.2 ml) Soluble system Ribosomal system 
Unfractionated 
leu-tRNA , 
leu-tRNA, 
leu-tRNA, 
leu-tRNA, 
phe-tRNA 
24.7 28.2 6.8 
21.3 34.0 5.1 
159.7 13.3 13.2 
63.9 17.7 8.7 
31.9 29.7 5.9 
312.5** 50.4 not determined 
*_K, values calculated from data in fig. 3 a,b,c, and d, 
**Lineweaver-Burk plot not shown. Experimental conditions as described in text. 
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4. Discussion 
Although no absolute specificity in the utilization 
of the four species could be demonstrated, the data 
suggest hat leu-tRNA I and leu-tRNAS which account 
for nearly 50% and 10% of the total leucine acceptor 
activity respectively are better utilized in the soluble 
incorporation system while the two relatively minor 
species participate to a greater extent in MS2 RNA di- 
rected ribosomal protein synthesis. 
It has been shown that in Tz infected E. coli, leu- 
tRNA, is poorly utilized suggesting that Tz mRNA 
rarely contains the leucine codon CUG [ 151. Wett- 
stein found thk leu-tRNA 1 is much less frequently 
bound to ribosomes intracellularly than the minor com- 
ponents and concluded that leu-tRNA1 might have a 
special function [ 161. Incorporation of leucine from 
leu-tRNA’s into hemoglobin however seems to indicate 
that both minor and inajor leu-tRNA species are utili- 
zed in the synthesis of ~1- and P-chains [ 171. 
It is tempting to speculate that the presence of iso- 
accepting aminoacyl-tRNA’s is not just a reflection of 
the degeneracy of the code, but provides a mechanism 
for the use of the tRNA’s in more than one biological 
function. The use of two specific glycyl-tRNA’s in the 
synthesis of protein and all three species in the synthe- 
sis of cell wall peptides is a good example of this case 
[ 181. In studies of incorporation of serine from seryl- 
tRNA similar findings have been made [ 191. In con- 
trast, however the isoaccepting species of threonyl- 
tRNA’s were all utilized to varying degrees in pepti- 
doglycan synthesis as well as in polypeptide synthesis 
using synthetic nucleotides as messengers [20]. An in- 
vestigation of their use in ribosomal systems program- 
med with homologous natural messengers would be of 
interest to determine whether the species of tRNA used 
for the synthesis of peptidoglycan is less used for pro- 
tein synthesis. While in ribosomal systems translational 
specificity involves codon-anticodon recognition, in 
aminoacylphosphatidylglycerol synthesis involving ly- 
syl- and alanyl-tRNA’s the enzymes show specificity 
both for the amino acid and the polynucleotide chain 
[21,22] . It appears possible that the transfer enzyme 
which is responsible for the amino terminal addition 
of the acceptor protein can distinguish the nucleotide 
sequence of various leu-tRNA’s in the same manner as 
in the case of aminoacylphosphatidylglycerol synthe- 
sis. On the other hand the preference of leu-tRNA1 
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for the soluble system may reside in the acceptor mole- 
cule. It is therefore possible that with an artificial ac- 
ceptor molecule such as bovine serum albumin [3] the 
preference for certain leu-tRNA’s may vary. 
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